HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price target.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 184 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
HC Wainwright & Co. Maintains Buy on Protara Therapeutics, Lowers Price Target to $30
HC Wainwright & Co. analyst Andrew Fein maintains Protara Therapeutics (NASDAQ:TARA) with a Buy and lowers the price target from $40 to $30.
Recap: Protara Therapeutics Q1 Earnings
Protara Therapeutics (NASDAQ:TARA) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
